Microbiota of Breast Tissue and Its Potential Association with Regional Recurrence of Breast Cancer in Korean Women

Abstract

Recent studies have reported dysbiosis of the microbiome in breast tissue collected from patients with breast cancer and the association between the microbiota and disease progression. However, the role of the microbiota in breast tissue remains unclear, possibly due to the complexity of breast cancer and various factors, including racial and geographical differences, influencing microbiota in breast tissue. Here, to determine the potential role of microbiota in breast tumor tissue, we analyzed 141 tissue samples based on three different tissue types (tumor, adjacent normal, and lymph node tissues) from the same patients with breast cancer in Korea. The microbiota was not simply distinguishable based on tissue types. However, the microbiota could be divided into two cluster types, even within the same tissue type, and the clinicopathologic factors were differently correlated in the two cluster types. Risk of regional recurrence was also significantly different between the microbiota cluster types (p = 0.014). In predicted function analysis, the pentose and glucuronate interconversions were significantly different between the cluster types (q < 0.001), and Enterococcus was the main genus contributing to these differences (q < 0.01). Results showed that the microbiota of breast tissue could interact with the host and influence the risk of regional recurrence. Although further studies would be recommended to validate our results, this study could expand our understanding on the breast tissue microbiota, and the results might be applied to develop novel prediction methods and treatments for patients with breast cancer.

The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine

“…The content of breast microbiota might have value in discriminating patients who are at higher risk of regional recurrence, as shown by Kim et al. ( 67 ). Of note, Porphyromonas , Lacibacter , Ezakiella , and Fusobacterium were more abundant in higher-stage versus lower-stage tumors.…”

The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer

“…Oncobiosis is also associated with disease recurrence. Kim et al reported that when comparing patients with high and low risk of regional recurrence of breast cancer, bacterial pentose and glucuronate interconversions and Enterococcus were the main discriminating factors [95]. In support of these observations, antibiotic overdosing can increase the likelihood of disease recurrence [29].…”

Major Microbiota Profile of Breast Cancer From Faecal Specimen and Cancerous Breast Tissue: A Comprehensive Systematic Review

“…Tzeng, et.al (2021) [12] 16S rRNA sequencing HER2+, ER+ 57 Fresh-frozen breast cancer tumor Proteobacteria, with either Firmicutes or Actinobacteria Shi, et.al (2019) [13] 16S rRNA sequencing HER2+, ER+, -Frozen fecal sample of breast cancer patient Actinobacteria Bacteroidetes, firmicutes, Fusobacteria, Proteobacteria Hieken, et.al (2022) [14] 16S rRNA sequencing ER+ 60 Benign and malignant breast tissue Firmicutes, staphylococcus Dubigeon, et. al (2021) [15] 16S rRNA sequencing HER2-, ER+ 63 Fecal microbiota breast cancer patient Firmicutes, Clostridium Blautia Kim, et.al (2021) [16] 16S rRNA sequencing ER+ (59,6% [17] 16S rRNA sequencing --Stool specimen of malignant breast Escherichia, Peptoniphilus, Bilophila, Lactobacillus, and Porphyromonas Lasagna, et.al (2022) [18] 16S rRNA sequencing ER/PR+ and HER2-Stool specimen from breast cancer patient…”